The UK's National Health Service (NHS) has announced the launch of a major clinical trial of a new blood test designed for early cancer detection. The study will involve tens of thousands of patients, making it one of the largest projects in this field. The trial aims to determine how effectively the test can detect signs of cancer at early stages, when treatment is usually more successful. Early cancer diagnosis is considered one of the key factors affecting patient survival, as it allows therapy to begin before the disease spreads. If the trial confirms the test's effectiveness, it could transform the approach to cancer screening in the healthcare system, making early diagnosis a more accessible and routine procedure. NHS specialists note that such tests have the potential to detect various types of cancer using a relatively simple and minimally invasive method — a blood draw — as opposed to more complex and expensive diagnostic procedures. The study results will be analyzed over a defined period, after which experts will assess the accuracy and reliability of the method. If successful, the technology could be implemented into broad clinical practice, potentially increasing the chances of detecting cancer before obvious symptoms appear in significantly more people.